Grifols S.A. Cl B | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
497,536.00
589,680.00
690,250.00
712,752.00
695,722.00
725,842
Depreciation, Depletion & Amortization
128,469.00
189,472.00
189,755.00
201,869.00
215,490.00
228,609
Other Funds
29,569.00
159,962.00
17,086.00
21,492.00
14,158.00
101,042
Funds from Operations
551,679.00
883,647.00
824,836.00
717,597.00
907,912.00
853,409
Changes in Working Capital
40,332.00
95,281.00
77,058.00
164,319.00
66,166.00
112,923
Net Operating Cash Flow
592,011.00
978,928.00
747,778.00
553,278.00
841,746.00
740,486
Capital Expenditures
172,849.00
287,039.00
567,020.00
292,690.00
322,973.00
Sale of Fixed Assets & Businesses
16,793.00
14,423.00
14,307.00
2,426.00
762.00
Net Investing Cash Flow
236,034.00
1,521,104.00
633,110.00
506,652.00
2,185,880.00
Cash Dividends Paid - Total
70,062.00
156,007.00
221,772.00
216,151.00
218,260.00
Issuance/Reduction of Debt, Net
79,413.00
1,226,339.00
28,953.00
80,149.00
1,666,483.00
Net Financing Cash Flow
105,146.00
841,118.00
163,038.00
329,558.00
1,434,065.00
Net Change in Cash
235,450.00
370,369.00
63,354.00
247,491.00
8,488.00
Free Cash Flow
453,551.00
743,034.00
225,191.00
303,862.00
590,239.00
Net Assets from Acquisitions
69,172.00
1,234,952.00
58,609.00
202,727.00
1,857,210.00
Other Sources
-
-
-
-
23,025.00
Change in Capital Stock
14,760.00
69,252.00
12,695.00
11,766.00
-
Exchange Rate Effect
15,381.00
71,427.00
111,724.00
35,441.00
98,419.00
Other Uses
10,806.00
13,536.00
21,788.00
13,661.00
29,484.00

About Grifols

View Profile
Address
Avinguda de la Generalitat, 152-158
Barcelona Catalonia 08174
Spain
Employees -
Website http://www.grifols.com
Updated 07/08/2019
Grifols SA is a vertically integrated global producer of plasma derivatives. Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers. The company operates through the following segments: Bioscience, Hospital, Diagnostic and Raw Materials.